NMRA

Neumora Therapeutics, Inc. Common Stock$1.62+0.04 (+2.53%)

Prev Close$1.58·MCap$292.7M·P/E—·Vol336.0K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$165.2K

◆

Net Activity

Net Seller

$165.2K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Neumora Therapeutics, Inc. Common Stock (NMRA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 8 insider sales totaling $165.2K. The most recent insider transaction was by Aurora Daljit Singh (officer: See Remarks), who sold $21.9K worth of shares on Feb 19, 2026. Neumora Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $292.7M.

NMRA Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 19, 2026	Aurora Daljit Singh	officer: See Remarks	Sell	6,165	$3.56	$21.9K	82,770
Feb 19, 2026	BERNS PAUL L	director, officer: See Remarks	Sell	9,819	$3.51	$34.5K	7,395,185
Feb 19, 2026	Milligan Michael Lee	officer: See Remarks	Sell	1,436	$3.57	$5.1K	21,034
Feb 19, 2026	Pinto Joshua	officer: President	Sell	5,967	$3.53	$21.1K	57,783
Feb 17, 2026	Aurora Daljit Singh	See Remarks	Sell	6,165	$3.56	$21.9K	0
Feb 17, 2026	BERNS PAUL L	See Remarks	Sell	9,819	$3.51	$34.5K	0
Feb 17, 2026	Milligan Michael Lee	See Remarks	Sell	1,436	$3.57	$5.1K	0
Feb 17, 2026	Pinto Joshua	President	Sell	5,967	$3.53	$21.1K	0
Feb 20, 2025	Aurora Daljit Singh	Chief Strategy Officer	Sell	8,565	$1.68	$14.3K	88,935
Feb 20, 2025	BERNS PAUL L	See Remarks	Sell	13,871	$1.69	$23.5K	7,405,004
Feb 20, 2025	Lenz Robert A.	Head of R&D	Sell	5,614	$1.67	$9.4K	309,092
Feb 20, 2025	Milligan Michael Lee	See Remarks	Sell	1,978	$1.69	$3.4K	22,470
Feb 20, 2025	Pinto Joshua	President	Sell	8,048	$1.67	$13.5K	76,952
Oct 18, 2024	Fust Matthew K		Sell	21,788	$17.03	$371.0K	20,100-52%
Oct 11, 2024	Lenz Robert A.	Head of R&D	Sell	13,823	$15.06	$208.1K	322,966
Sep 19, 2024	Lenz Robert A.	Head of R&D	Sell	41,464	$11.89	$492.8K	339,205
Sep 16, 2024	Lenz Robert A.	Head of R&D	Sell	32,948	$11.43	$376.7K	369,993
Aug 27, 2024	Pinto Joshua	Chief Financial Officer	Sell	15,693	$11.39	$178.8K	138,965
Aug 26, 2024	Pinto Joshua	Chief Financial Officer	Sell	84,307	$11.67	$984.1K	210,469-29%
Nov 15, 2023	Burow Kristina	Director	Buy	35,010	$11.77	$412.1K	4,131,207
Nov 13, 2023	Burow Kristina	Director	Buy	140,605	$10.98	$1.54M	4,096,197
Nov 7, 2023	Burow Kristina	Director	Buy	95,694	$11.49	$1.10M	3,955,592
Sep 29, 2023	Burow Kristina	Director	Buy	76,511	$13.68	$1.05M	3,859,898
Sep 27, 2023	Burow Kristina	Director	Buy	58,504	$11.97	$700.5K	3,783,387
Sep 25, 2023	ARCH Venture Partners XII, LLC	10% Owner	Buy	100,740	$11.19	$1.13M	3,724,883
Sep 20, 2023	Burow Kristina		Buy	1,500,000	$17.00	$25.50M0.9% OS	3,624,143+71%
Sep 19, 2023	AMGEN INC		Buy	1,764,705	$17.00	$30.00M1.1% OS	35,368,652
Sep 19, 2023	Gosebruch Henry O	President & CEO	Buy	15,000	$12.62	$189.4K	15,000

NMRA Insider Buying Activity

The following table shows recent insider purchases of Neumora Therapeutics, Inc. Common Stock (NMRA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Nov 15, 2023	Burow Kristina	Director	Buy	35,010	$11.77	$412.1K	4,131,207
Nov 13, 2023	Burow Kristina	Director	Buy	140,605	$10.98	$1.54M	4,096,197
Nov 7, 2023	Burow Kristina	Director	Buy	95,694	$11.49	$1.10M	3,955,592
Sep 29, 2023	Burow Kristina	Director	Buy	76,511	$13.68	$1.05M	3,859,898
Sep 27, 2023	Burow Kristina	Director	Buy	58,504	$11.97	$700.5K	3,783,387
Sep 25, 2023	ARCH Venture Partners XII, LLC	10% Owner	Buy	100,740	$11.19	$1.13M	3,724,883
Sep 20, 2023	Burow Kristina		Buy	1,500,000	$17.00	$25.50M0.9% OS	3,624,143+71%
Sep 19, 2023	AMGEN INC		Buy	1,764,705	$17.00	$30.00M1.1% OS	35,368,652
Sep 19, 2023	Gosebruch Henry O	President & CEO	Buy	15,000	$12.62	$189.4K	15,000

NMRA Insider Selling Activity

The following table shows recent insider sales of Neumora Therapeutics, Inc. Common Stock (NMRA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 19, 2026	Aurora Daljit Singh	officer: See Remarks	Sell	6,165	$3.56	$21.9K	82,770
Feb 19, 2026	BERNS PAUL L	director, officer: See Remarks	Sell	9,819	$3.51	$34.5K	7,395,185
Feb 19, 2026	Milligan Michael Lee	officer: See Remarks	Sell	1,436	$3.57	$5.1K	21,034
Feb 19, 2026	Pinto Joshua	officer: President	Sell	5,967	$3.53	$21.1K	57,783
Feb 17, 2026	Aurora Daljit Singh	See Remarks	Sell	6,165	$3.56	$21.9K	0
Feb 17, 2026	BERNS PAUL L	See Remarks	Sell	9,819	$3.51	$34.5K	0
Feb 17, 2026	Milligan Michael Lee	See Remarks	Sell	1,436	$3.57	$5.1K	0
Feb 17, 2026	Pinto Joshua	President	Sell	5,967	$3.53	$21.1K	0
Feb 20, 2025	Aurora Daljit Singh	Chief Strategy Officer	Sell	8,565	$1.68	$14.3K	88,935
Feb 20, 2025	BERNS PAUL L	See Remarks	Sell	13,871	$1.69	$23.5K	7,405,004
Feb 20, 2025	Lenz Robert A.	Head of R&D	Sell	5,614	$1.67	$9.4K	309,092
Feb 20, 2025	Milligan Michael Lee	See Remarks	Sell	1,978	$1.69	$3.4K	22,470
Feb 20, 2025	Pinto Joshua	President	Sell	8,048	$1.67	$13.5K	76,952
Oct 18, 2024	Fust Matthew K		Sell	21,788	$17.03	$371.0K	20,100-52%
Oct 11, 2024	Lenz Robert A.	Head of R&D	Sell	13,823	$15.06	$208.1K	322,966
Sep 19, 2024	Lenz Robert A.	Head of R&D	Sell	41,464	$11.89	$492.8K	339,205
Sep 16, 2024	Lenz Robert A.	Head of R&D	Sell	32,948	$11.43	$376.7K	369,993
Aug 27, 2024	Pinto Joshua	Chief Financial Officer	Sell	15,693	$11.39	$178.8K	138,965
Aug 26, 2024	Pinto Joshua	Chief Financial Officer	Sell	84,307	$11.67	$984.1K	210,469-29%